BugSeq

We're empowering microbiology labs to prevent and treat infections with nucleic acid sequencing.

[BugSeq @bugseq]

BugSeq leads clinical bioinformatics in consortium (@Ginkgo, @JumpcodeG , @planetinnovate , @TGenResearch , and more) developing end-to-end metagenomic solution for @EU_HaDEA.

See our announcement here: https://t.co/Ool9v1SHmF

[Ginkgo Bioworks @Ginkgo]

Today, we're thrilled to announce RANGER: RApid Next Generation Sequencing for Effective Medical Response, a consortium project supported by the @EU_HaDEA.

https://t.co/3Sg58dX5Fs

[BugSeq @bugseq]

Going to #AMP2026 in Seattle? Find BugSeq at Booth 845, and let’s chat about your sequencing and bioinformatics!
@AMPath

[BugSeq @bugseq]

Missed our webinar on fungal pathogen sequencing? The full recording is now live!

Learn how experts from @TGHCares and @JessaZiekenhuis leverage @nanopore sequencing alongside BugSeq to streamline and accelerate fungal analysis.

https://t.co/5gn4AOuAFv

[BugSeq @bugseq]

High-quality input yields high-confidence results. Optimized extraction, library prep, and sequencing protocols ensure that BugSeq can provide analytical accuracy with their bioinformatics workflows. Learn how to optimize your end-to-end workflow: https://t.co/X9cDVLLiBr

[BugSeq @bugseq]

@ColumbiaMed deployed BugSeq’s software to analyze C. auris isolates from their hospital. 100% of isolates had one or more anti-fungal resistant mutations. BugSeq identified multiple circulating lineages and accurately predicted antifungal resistance. https://t.co/nJqOZOe2gH

[BugSeq @bugseq]

Only one more day to register for this webinar by @nanopore and BugSeq!

[Oxford Nanopore @nanopore]

Join researchers from Jessa Hospital and Tampa General Hospital who will share their clinical research workflow considerations, validation data, and implementation insights using nanopore sequencing and BugSeq analysis for fungal pathogen ID.

https://t.co/oh70H77ERs

RUO

[BugSeq @bugseq]

Don’t miss BugSeq in the Innovation & Pipeline Theatre today, Oct 22 at 1:00 PM! ⏱️

We will be presenting "Leveraging AI to Accurately Predict Antimicrobial Resistance from Next-Generation Sequencing Data" at @IDWeekmtg. See you there! 🧠🔬

#IDWeek #IDWeek2026

[BugSeq @bugseq]

📍 Going to @IDWeekmtg? Stop by Booth 1814 to meet the BugSeq team!

Discover how we are transforming infectious disease diagnostics with our next-generation sequencing analytics. Let’s connect in Washington, D.C.! 🧬💻

#IDWeek #IDWeek2026

[BugSeq @bugseq]

From targeted ITS sequencing direct from sample to WGS for outbreak strain typing: see how @nanopore and BugSeq enable rapid fungal pathogen characterisation.

Register (offered in two time zones):
https://t.co/YrvkRahQdc

[Oxford Nanopore @nanopore]

Join researchers from Jessa Hospital and Tampa General Hospital who will share their clinical research workflow considerations, validation data, and implementation insights using nanopore sequencing and BugSeq analysis for fungal pathogen ID.

https://t.co/oh70H77ERs

RUO

[BugSeq @bugseq]

As metagenomic next-generation sequencing technology is increasingly used in clinical laboratories, BugSeq announces two new efforts to push mNGS technology towards regulated diagnostic use.

Read the full details here: https://t.co/QrhCxL2QEb

[BugSeq @bugseq]

Another great example from the team at @JessaZiekenhuis using BugSeq to analyze @nanopore sequencing data in routine clinical microbiology!

https://t.co/FPG8VYrQ0V

[BugSeq @bugseq]

.@JessaZiekenhuis, evaluating BugSeq for characterization of #AMR and outbreak analysis in Pseudomonas aeruginosa, found “the overall categorical agreement (% [95% CI]) between AMR genotype and phenotype was 94.76% [92.46%–96.52%]”.

Read more: https://t.co/0Tw4zdLK8V

[GenomeBC @GenomeBC]

New genomic tools are helping strengthen Canada's response to emerging pathogens and antimicrobial resistance.
@techcouver
@bugseq
Read more: https://t.co/Wa03ThE9Kn

#Genomics #PublicHealth #AMR #AntimicrobialResistance #InnovationBC

[BugSeq @bugseq]

.@JessaZiekenhuis, evaluating BugSeq for characterization of #AMR and outbreak analysis in Pseudomonas aeruginosa, found “the overall categorical agreement (% [95% CI]) between AMR genotype and phenotype was 94.76% [92.46%–96.52%]”.

Read more: https://t.co/0Tw4zdLK8V

[BugSeq @bugseq]

Speed up your lab's #Cyclospora surveillance with the BugSeq platform. Contact us for early access to our new Cyclospora cayetanensis MLST module, which delivers typing from WGS and metagenomics!

[BugSeq @bugseq]

We’re proud to team up with @GenomeBC on a new initiative to advance #Genomics in the fight against antimicrobial resistance!
From scaling our #BugAMR platform to refining tools for rapid pathogen detection, we’re focused on one goal: faster, life-saving insights for healthcare.

[GenomeBC @GenomeBC]

2 new research projects with BC-based biotech company @bugseq to advance genomic tools that improve antimicrobial resistance prediction and respiratory pathogen detection.
Faster answers. Better treatment decisions. Stronger public health systems.
https://t.co/LBCKPYSzcL

[BugSeq @bugseq]

https://t.co/dN1oghIA2Z

[BugSeq @bugseq]

Fantastic demonstration by the @AdventHealth team of the power of BugSeq in clinical practice: “Rapid and Routinely 24-Hour Antimicrobial Resistance Report for Mycobacterium abscessus Group by Whole-Genome Sequencing: A Tool for Appropriate Antimicrobial Therapy” 👇

[BugSeq @bugseq]

Join BugSeq at ASM Microbe to see innovation in action! See the full BugSeq schedule, including demonstrations from our users: https://t.co/1f7RdqHGGS

[BugSeq @bugseq]

Check out recent updates to the BugSeq platform in our latest blog post: Advancing Viral Surveillance, Sequencing Flexibility, AMR Prediction, and EPI2ME Integration

https://t.co/bBgSBzPbW0

[BugSeq @bugseq]

Discover how public health laboratories are integrating BugSeq into their everyday bioinformatics routines! Visit us at booth 200 at @APHL 2026; we are eager to learn about the challenges you face and discuss how our solutions can support your work. #APHL

[BugSeq @bugseq]

At #PASCV2026 ? Drop by the BugSeq booth (02T) to see how the most innovative labs are leveraging NGS to track viral outbreaks, antiviral resistance and more (and don’t forget to grab a notebook or bag)!